I Hate Dialysis Message Board
Dialysis Discussion => Dialysis: News Articles => Topic started by: kickingandscreaming on January 13, 2017, 07:13:54 AM
-
Baxter Healthcare Corporation to Pay More Than $18 Million to Resolve Liability
https://www.justice.gov/opa/pr/baxter-healthcare-corporation-pay-more-18-million-resolve-criminal-and-civil-liability
Department of Justice
Office of Public Affairs
FOR IMMEDIATE RELEASE
Thursday, January 12, 2017
Baxter Healthcare Corporation to Pay More Than $18 Million to Resolve Criminal and Civil Liability Relating to Sterile Products
Company Failed to Follow Good Manufacturing Practices in North Carolina Facility
Healthcare company Baxter Healthcare Corporation (Baxter) has agreed to pay $18.158 million to resolve its criminal and civil liability arising from Baxter’s failure to follow current Good Manufacturing Practices (cGMP) when manufacturing sterile drug products in North Carolina, the Department of Justice announced today. Today’s resolution includes a deferred prosecution agreement and penalties and forfeiture totaling $16 million and a civil settlement under the False Claims Act (FCA) with the federal government totaling approximately $2.158 million. Baxter is a Delaware corporation and subsidiary of Baxter International Inc., headquartered in Deerfield, Illinois, with many manufacturing facilities throughout the United States and the world, including one in Marion, North Carolina (North Cove).
In a criminal information filed today in the Western District of North Carolina, the government charged that, between July 2011 and November 2012, Baxter introduced into interstate commerce drugs that were adulterated under the Federal Food, Drug, and Cosmetic Act (FDCA) because Baxter did not follow cGMP when making those products. At North Cove, Baxter manufactured large-volume sterile intravenous (IV) solutions in a clean room that had high-efficiency particulate absorption (HEPA) filters installed in the ceiling. Air was pushed into the clean room through the HEPA filters. As alleged in the information, during the relevant time period, a Baxter employee reported the presence of mold on the HEPA filters to plant management. However, Baxter continued to manufacture IV solutions in that clean room for months while the filters the employee had identified as moldy remained in place. Subsequent testing of the filters following an unannounced U.S. Food and Drug Administration (FDA) inspection revealed several mold species on the filters. There was no evidence of impact on the IV solutions from the mold found on the filters.
In a deferred prosecution agreement to resolve the charge, Baxter admitted that it distributed products in interstate commerce that were adulterated in violation of the FDCA. Under the terms of the deferred prosecution agreement, Baxter will pay a total of $16 million in monetary penalties and forfeiture and will implement enhanced compliance provisions, including periodic certifications to the government concerning its implementation of those provisions. The deferred prosecution agreement will not be final until accepted by the U.S. District Court.
(snip)
In addition, Baxter will pay approximately $2.158 million to resolve allegations that the company violated the FCA by submitting false claims to the Department of Veterans Affairs based upon Baxter’s failure to follow cGMPs.
The civil settlement resolves a lawsuit filed by Christopher Wall, an employee of Baxter, under the whistleblower provision of the False Claims Act, which permits private parties to file suit on behalf of the United States for false claims and share in a portion of the government’s recovery. The civil lawsuit was filed in the Western District of North Carolina and is captioned United States ex rel. Christopher Wall v. Baxter International, Inc. et al., No. 13cv42 (W.D.N.C.). Mr. Wall will receive $431,535.99 from the proceeds of the civil settlement.
(snip)
-
Corporate Greed. Thos efilters were expensive. Someone decided NOT to replace them and continued business as usual.
They are very fortunate product was not so contaminated that people sickened, this time.
Corporate Greed drives many wrong decision solely to improve profits. Until Corporations stop worshiping profit and begin pushing for quality with a more modest profit, we will continue to find cases such as this,
There are provisions to prosecute individuals when those decision boarder on Criminal. And these should be used more often. Start holding individuals accountable for their decision should make then stop and thinnk. Before potentially risking consumers health.
-
We had a compounding pharmacy in Framingham, MA that shipped thousands of vials of fungus contaminated spinal injections and killed a bunch of people. The owner is being prosecuted.
-
That's terrible. If he ws aware that is just about murder. They will charge manslaughter at most. Simply terrible anyway you look at it.